Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432. (Q37327280)
Jump to navigation
Jump to search
scientific article published on 06 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432. |
scientific article published on 06 March 2012 |
Statements
1 reference
Pharmacokinetics and safety of bortezomib in patients with advanced malignancies and varying degrees of liver dysfunction: phase I NCI Organ Dysfunction Working Group Study NCI-6432. (English)
1 reference
Patricia M LoRusso
1 reference
Karthik Venkatakrishnan
1 reference
Ramesh K Ramanathan
1 reference
John Sarantopoulos
1 reference
Daniel Mulkerin
1 reference
Stephen I Shibata
1 reference
Anne Hamilton
1 reference
Afshin Dowlati
1 reference
Sridhar Mani
1 reference
Michelle A Rudek
1 reference
Chris H Takimoto
1 reference
Rachel Neuwirth
1 reference
Dixie-Lee Esseltine
1 reference
Percy Ivy
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference